Author Archives: yun

Association between neurodevelopmental outcomes and concomitant presence of NEC and IVH in extremely low birth weight infants

Abstract Objective To quantify the association between necrotizing enterocolitis (NEC) and neurodevelopmental disability (NDI) in extremely low birth weight (ELBW) infants with intraventricular hemorrhage (IVH). Study design ELBW survivors born 2011–2017 and evaluated at 16–26 months corrected age in the Vermont Oxford Network (VON) ELBW Follow-Up Project were included. Logistic regression determined the adjusted relative […]

Monash-led national program to improve treatments for kids with muscle

You are here: 21 September 2023 A national clinical consortium has joined forces to improve care outcomes for children born with congenital muscle disease, led by Monash University’s Professor Peter Currie.   Enabled by a $2.5million Medical Research Future Fund grant received in 2021, the ‘Australian functional Diagnostics platform for Advancing Personalised Treatment of Congenital Muscle […]

New recommendations for blood pressure screenings

BISMARCK, N.D. (KFYR) – A recent study found doctors might be able to better predict who’s at risk for having a cardiac event by also taking a patient’s blood pressure while they’re lying down. Some of the participants who would have normally been considered fine using just a sitting blood pressure reading were found to […]

Aeromonas skin infections outbreak linked to Tough Mudder adventure race at Sonoma Raceway

NewsDesk @bactiman63 The County of Sonoma Department of Health Services has issued a Health Advisory concerning multiple reports of participants in a Tough Mudder race at Sonoma Raceway on Aug. 19 and 20 having developed rash with fever, muscle pain, or nausea/vomiting occurring about 24 hours after the event. Image/David Benbennick Numerous race participants have experienced […]

Kiszla: We wanted Buffs vs. Rams to be a blood feud, then were shocked when CU star Travis Hunter got hurt?

A lacerated liver for CU Buffs star Travis Hunter is the price of doing business, when doing what’s right or wrong doesn’t really matter in college football, so long as the hype machine keeps printing money. And aren’t victories for money the bottom-line reason why Deion Sanders is here? While responsibility for the cheap shot […]

In-Depth: Should you get a COVID-19 booster? An infectious disease doctor shares advice

LEXINGTON, Ky. (LEX 18) — Kentuckians continue to weigh getting the new COVID-19 booster shot as cases and hospitalizations spike. The new booster is supposed to be available at physician offices and pharmacies this week, but not everyone has decided to take it. Dr. Nicholas Van Sickel, Infectious Disease Physician and Interim Director of Infection […]

Traumatic brain injury under-recognized as a risk factor for cardiovascular disease, says new study

Credit: Unsplash/CC0 Public Domain Traumatic brain injury (TBI) is a leading cause of long-term disability and premature death, especially among military personnel and those playing contact sports. Substantial research has examined acute and chronic neurological consequences of TBI; however, non-neurological conditions associated with TBI are understudied. A new review paper by investigators from Mass General […]

Our Blood Institute holds workshop for area students in Lawton

LAWTON, Okla. (KSWO) – Today, Our Blood Institute, or OBI, held a workshop for high school students in the area for them to learn about the importance of blood donations. Darby Huffstutler with OBI says 30% of their donations come from high school and college students, they wanted to let them know how important they […]

Global Congenital Adrenal Hyperplasia Treatment Market Anticipates Robust Growth, Fueled by Rising Disease Prevalence and Research Investments

DUBLIN, Sept. 20, 2023 /PRNewswire/ — The “Global Congenital Adrenal Hyperplasia Treatment Market Report and Forecast 2023-2031” report has been added to  ResearchAndMarkets.com’s offering. The global congenital adrenal hyperplasia treatment market is poised for substantial growth during the forecast period of 2023-2031. This growth is primarily driven by the increasing prevalence of congenital adrenal hyperplasia worldwide […]

Behind the FDA Approval: Momelotinib for Myelofibrosis and Anemia

Aaron T. Gerds, MD, MS The FDA approval of momelotinib (Ojjaara) has provided a potentially new standard-of-care treatment option for patients with myelofibrosis who have anemia, and according to Aaron T. Gerds, MD, MS, findings from the phase 3 MOMENTUM trial (NCT04173494) serve as the basis of this approval. In the international, randomized, double-blind, controlled […]